BridgeBio Pharma, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
BBIO on Nasdaq
Location
3160 Porter Dr., Suite 250, Palo Alto, CA

Insiders trading volume in the past year

BridgeBio Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viking Global Investors Lp 10%+ Owner $816M -$261M -24.2% Jun 27, 2025
KKR Genetic Disorder L.P. 10%+ Owner $454M -$403M -47% May 12, 2025
Neil Kumar Chief Executive Officer, Director $381M -$57.8M -13.2% Nov 20, 2025
Frank Mccormick Director $51.4M -$21.7M -29.7% Oct 29, 2025
Charles J. Homcy Director $44M -$13.9M -24% Aug 8, 2025
Thomas Trimarchi President and CFO $25.6M -$4.09M -13.8% Nov 16, 2025
Maricel Apuli Chief Accounting Officer $8.78M -$84.9K -0.96% Nov 16, 2025
Brian C. Stephenson CFO and Treasurer $6.44M -$2.9M -31% Feb 25, 2025
Ali J. Satvat Director $5.78M Jun 20, 2025
Andrew Lo Director $4.29M -$10.2M -70.4% Nov 17, 2025
James C. Momtazee Director $3.31M Jun 20, 2025
Richard H. Scheller Director $2.42M Feb 16, 2023
Daniels Ronald J Director $1.08M -$3.89M -78.2% Nov 6, 2025
Randal W. Scott Director $1.04M -$666K -39% Nov 17, 2025
Douglas A. Dachille Director $927K Jun 20, 2025
Andrea Ellis Director $911K -$2.21M -70.8% Aug 5, 2025
Fred Hassan Director $902K Jun 20, 2025
Brent L. Saunders Director $668K Jun 22, 2022
Hannah Valantine Director $514K -$2.48M -82.8% Nov 12, 2025
Jennifer Cook Director $479K Jun 20, 2025
Eric Aguiar Director $230K Jun 20, 2025

Recent Insider Transactions by Companies or Individuals for BridgeBio Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.